Post-COVID-19 clinics offer hope to coronavirus survivors

And they may help doctors improve treatments for tomorrow’s patients.

When the pandemic began, healthcare workers had one objective: figure out how to keep patients alive. But as the population of coronavirus survivors grew, they started to realize that a patient’s battle with COVID-19 didn’t always end after a negative test result.

“In the early days, it looked like there was a group of patients who got sick and got well, and a group of patients who got sick and died,” Zijian Chen, an endocrinologist at Mount Sinai Hospital, told the Association of American Medical Colleges (AAMC) in August.

“Now there’s an ever-growing group that gets sick and stays sick. That may be tens of thousands of people,” Chen said. “The goal now is to figure out how best to get care to as many of them as possible.”

A growing number of hospitals have launched post-COVID-19 clinics, a new type of facility where specialists from a variety of fields treat — and study — coronavirus survivors.

Today’s Post-COVID-19 Clinics

Months into their recovery, some coronavirus survivors continue to suffer from physical ailments, such as chest pain or fatigue, while others experience mental health effects, such as depression, anxiety, and “brain fog.”

At post-COVID-19 clinics, workers can test patients for these problems and then connect them to cardiologists, psychiatrists, and every kind of specialist in between for treatment.

To reach coronavirus survivors, some post-COVID-19 clinics proactively follow up with patients every few weeks after they leave the hospital, or, if they weren’t hospitalized, after they receive a diagnosis.

In other cases, coronavirus survivors actively seek out the clinics. All too often, this is because they’re having trouble getting the medical help they need through traditional routes — many report having their symptoms dismissed by doctors.

“In an ideal world, with these post-COVID-19 clinics, you can identify the patients and get them into rehab,” James Jackson, director of long-term outcomes at the Vanderbilt University’s ICU Recovery Center, told CNN in September.

“Even if the primary thing these clinics did was to say to patients, ‘This is real, it is not all in your head,’ that impact would be important,” he added.

Helping Tomorrow’s Coronavirus Survivors

Post-COVID-19 clinics might not just benefit today’s coronavirus survivors — the facilities might also help healthcare workers treat the survivors of the future.

Right now, researchers have very little understanding of the connection between certain patients and certain lingering symptoms. People with mild cases can have severe post-COVID-19 issues and vice versa.

By following up with a lot of patients, researchers might be able to gather enough data to connect the dots between patients and lingering coronavirus symptoms.

Armed with that knowledge, they might then be able to figure out how to minimize the long-term health effects of COVID-19 — or maybe even eliminate them altogether.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

Related
New Alzheimer’s drug slows mental decline by 27% in clinical trial
Eisai and Biogen are reporting that their new Alzheimer’s antibody slowed cognitive decline by 27% in a global trial.
What’s causing the alarming rise in cancer for adults under 50?
A new review finds that 14 different cancers, including eight related to the digestive system, are increasing in people under age 50.
I’ve had COVID and am constantly getting colds. Did COVID harm my immune system?
Does COVID somehow weaken the immune system to make us more prone to other infectious diseases? Here’s what scientists know.
Meth addiction treatments are finally on the horizon
New antibody and drug therapies may soon help treat meth patients, who currently have no pharmacological interventions.
Blood test can find dozens of types of cancer, with few false positives
Grail’s Galleri multi-cancer blood test found multiple cancers in a study of over 6,000 patients.
Up Next
compare covid-19 vaccines
Subscribe to Freethink for more great stories